News

The study is designed to determine the safety and pharmacokinetics of multiple ascending oral doses of DB959Na in both male and female subjects. The study results are estimated

Phoenix is a PK/PD modeling software platform that includes a range of tools that can be used individually or together. Pharsight claims the advanced Phoenix will support Windows

Bioniche Pharma claims Octreotide Acetate Injection USP is the generic version of Novartis’ Sandostatin, indicated for the treatment of acromegaly. The injection was developed by Chemi and is

As per the terms of the agreement, Merck, through a subsidiary, will initiate a tender offer for all outstanding common stock of Inspireat a price of $5 per

Aragen Bioscience has received three subcontracts to produce and characteriza stable cell lines expressing antibodies against polio virus, pandemic influenza virus and Candida albicans, and to develop cell

The newly-issued patent relates to the GeNO cartridge technology that eliminates nitrogen dioxide (NO2) from the gas being delivered to the patient. Out of two Phase 2 trials,

Pursuant to the proposed merger, Evolva is expected to take over 100% of the share capital of Abunda in return for 25m Evolva shares (12.9% of Evolva’s share

Abstral , which is already marketed by ProStrakan across the European markets has got the US Food and Drug Administration approval in January 2011. Abstral is based on

As per the terms of the agreement, Neomycin Sulfate tablets will be manufactured by Oman Pharma, and marketed and distributed by Breckenridge on an exclusive basis in the